Tesamorelin 10mg
The Premier GHRH Analogue for Targeted Visceral Adipose Reduction
Tesamorelin is a highly stabilized, synthetic analogue of growth hormone-releasing hormone (GHRH). By incorporating a unique trans-3-hexenoic acid group to extend its biological half-life, it produces a robust and sustained release of endogenous growth hormone. It stands out in the research field as the single most effective peptide for specifically targeting and reducing deep visceral adipose tissue (VAT).
Key Research Benefits:
- Profound Visceral Fat Reduction: Powerfully stimulates the pituitary gland to release natural GH, driving highly targeted lipolysis to break down stubborn visceral fat in metabolic and lipodystrophy models.
- Elevated IGF-1 Levels: Significantly increases circulating Insulin-like Growth Factor 1 (IGF-1), accelerating tissue repair, recovery, and lean mass preservation.
- Optimized Lipid Profiles: Consistently demonstrated to lower triglycerides and improve overall cholesterol ratios in clinical research, making it an exceptional tool for studying metabolic health.
- Preserved Glucose Tolerance: Unlike direct exogenous GH administration, Tesamorelin enhances the GH/IGF-1 axis while maintaining a much safer profile for insulin sensitivity and glucose homeostasis.
Storage & Handling:
- Store lyophilised powder at −20°C (4°C for up to 4 weeks). Reconstitute carefully with bacteriostatic water. Store reconstituted solution at 4°C, protect from light, and use within 28 days.
